Shareholder plans sale of 50,000 shares

A shareholder plans to sell 50,000 common shares under Rule 144, to be executed through Morgan Stanley Smith Barney LLC on or around January 14, 2026 on the NASDAQ.

Accepted by SEC EDGAR 01/14/2026 - 04:27 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

A shareholder plans to sell 50,000 common shares under Rule 144, to be executed through Morgan Stanley Smith Barney LLC on or around January 14, 2026 on the NASDAQ. The filing shows an aggregate market value of $4,374,000 for this block, compared with 386,401,201 common shares outstanding. The shares were acquired as founder shares from the issuer on November 13, 2017 in a non-cash transaction.

Over the prior three months, the notice lists multiple Rule 10b5-1 sales of common stock for Michael Intrator and Omnadora Capital LLC, often in 50,000-share and 32,455-share blocks, with individual trade proceeds frequently in the millions of dollars. It also notes a 75,000-share sale by a non-affiliate donee. By signing, the selling person represents that they are not aware of undisclosed material adverse information about the issuer.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does this Form 144 filing for CRWV disclose?

The notice discloses a planned sale of 50,000 common shares of the issuer’s stock under Rule 144, with an aggregate market value of $4,374,000, to be executed on or about January 14, 2026 on the NASDAQ.

Who is associated with the recent CRWV share sales listed in the Form 144?

The document lists multiple recent common stock sales for Michael Intrator and Omnadora Capital LLC under 10b5-1 trading plans, as well as a 75,000-share sale by a non-affiliate donee.

How many CRWV shares are being proposed for sale and at what value?

The filing shows a proposed sale of 50,000 common shares with an aggregate market value of $4,374,000, using Morgan Stanley Smith Barney LLC as broker.

When and how were the CRWV shares to be sold originally acquired?

The 50,000 shares to be sold were acquired on November 13, 2017 as founder shares from the issuer, with the nature of payment described as N/A, indicating no cash purchase at that time.

What are the recent 10b5-1 trading activities mentioned in the CRWV Form 144?

During the last three months, the notice lists several 10b5-1 sales for Michael Intrator and Omnadora Capital LLC, including repeated 50,000-share and 32,455-share transactions, each generating multi-million dollar gross proceeds.

How many CRWV shares are outstanding according to this filing?

The securities information section reports that there are 386,401,201 common shares outstanding for the issuer.

What representation does the selling person make in this CRWV Form 144?

By signing, the person for whose account the securities are sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002058037
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	COREWEAVE, INC.
SEC File Number	001-42563
Address of Issuer	290 W Mt. Pleasant Ave. Suite 4100 Livingston NEW JERSEY 07039
Phone	9732709737
Name of Person for Whose Account the Securities are To Be Sold	OMNADORA CAPITAL LLC
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer
Relationship to Issuer	10% Stockholder

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	50000	4374000.00	386401201	01/14/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/13/2017	Founders Shares	Issuer			50000	11/13/2017	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	01/06/2026	61386	4674746.47
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/31/2025	32456	2334725.61
MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/31/2025	78971	5731033.94
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/31/2025	50000	3596755.00
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/17/2025	32455	2124981.39
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/17/2025	50000	3273735.00
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/03/2025	32455	2495279.96
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/03/2025	50000	3844215.00
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	11/19/2025	32455	2424654.63
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	11/19/2025	50000	3735410.00
Non-Affiliate Donee 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	11/14/2025	75000	5946097.50
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	11/05/2025	32455	3698951.52
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	11/05/2025	50000	5698585.00
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	10/22/2025	32455	3848449.75
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	10/22/2025	50000	5928688.75

144: Remarks and Signature

Remarks
Date of Notice	01/14/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/23/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Michael Intrator
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)